fda approves semaglutide First Treatment to Reduce Risk of Serious Heart Problems Specifically in Adults with Obesity FDA Approves Oral Semaglutide: First

With growing interest from patients and healthcare providers alike, these injectable treatments are changing the way we approach metabolic health

Dry mouth - a persistent feeling of dryness in the mouth and throat that isn't immediately relieved by drinking water - is a reported side effect of Mounjaro that's separate from generalised thirst

When you stop taking semaglutide, the appetite suppression fades within a few weeks, and most people regain a significant portion of their lost weight over the following six to twelve months

- March 13, 2025 - AM-PR Chicago-area patients now have access to precision medicine for obesity care with genetic obesity test from Phenomix Sciences

Its been seen in rats but not in humans

For the scenario of "Type 2 diabetes glycemic control," research data suggests Liraglutide may be more relevant